No phaseRecruitingAge-related condition

Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor β (ATHERO-FOL)

Sponsor
Turku University Hospital (Government)
Enrollment
90 planned
Conditions
Atheroscleroses; Inflammation
Interventions
18F-AlF-NOTA-Folate PET
Ages
adults, older adults
Registry
NCT07877324

Full record on ClinicalTrials.gov

From the registry

This study investigates inflammation in the blood vessels of people with coronary artery disease (CAD) or a recent myocardial infarction. Inflammation plays an important role in the development and progression of atherosclerosis, but there is currently no established clinical imaging method for detecting inflammation in atherosclerotic plaques throughout the body. The study uses a new PET imaging tracer called 18F-AlF-NOTA-Folate. The tracer is designed to bind to folate receptor beta (FR-β), a marker found on activated macrophages, which are immune cells involved in inflammation. The aim is to determine whether PET imaging with this tracer can detect and measure inflammation in atherosclerotic plaques. Approximately 90 patients will participate. One group will include patients with suspected or stable coronary artery disease who are undergoing coronary CT angiography and PET imaging as part of their clinical assessment. A second, smaller group will include patients who have recently had a myocardial infarction. Participants will undergo PET and CT imaging and provide blood…

Primary outcomes

  • Coronary 18F-AlF-NOTA-Folate uptake measured by a target-to-background ratio
  • 18F-AlF-NOTA-Folate uptake in extracardiac arteries measured by TBR

History

  1. Study completion expected

  2. Primary completion expected

  3. Registered

  4. Started